March 31, 2014

9 most counterfeited products in the USA


Global Innovation Policy Center @globalIPcenter 1h

“Waiving drug companies' intellectual property rights risks setting a bad precedent for future investment in new drugs. And that risk may not be worth it without additional steps to meaningfully increase the availability of shots across the world.”

Reply Retweet Favorite

Subscribe for updates from GIPC